The impact of a co-payment increase on the consumption of type 2 antidiabetics – A nationwide interrupted time series analysis

Hanna Rättö, Terhi Kurko, Jaana E. Martikainen and Katri Aaltonen

Health Policy, 2021, vol. 125, issue 9, 1166-1172

Abstract: International literature suggests that co-payment increases are associated with decreased medicine use, although the effects depend on context. We examined the impact of a co-payment increase on the consumption of type 2 antidiabetics in Finland, a country with a comprehensive health and social security system including ceiling mechanisms aiming to protect patients from high co-payment expenditures.

Keywords: Antidiabetics; Cost sharing; Cost containment; Policy evaluation; Health Reform (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851021001342
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:125:y:2021:i:9:p:1166-1172

DOI: 10.1016/j.healthpol.2021.05.007

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().